SUPPLEMENTARY INFORMATION
. A) List of the drugs analyzed in the paragraph "Contribution of known drug targets and of their known interaction partners to the cellular drug response".
Drugs are reported together with their known targets and the proteins associated to their known targets using protein-protein interaction and pathway data. B) Comparison of average performances of different combination of gene sets (P1, P2, P3 and F2) with 3 different prediction methods (Elastic Net Regression, Random Forest and Support Vector Regression).
Supplementary Table S2. A) List of genes selected as Drug-Unspecific Genes (DUG). B)
Gene Ontology terms enriched in DUG. C) Performance of machine learning methods with different variance-based selection of genes. D) Average performance of DUG with different machine learning methods (Elastic Net Regression, Random Forest and Support Vector Regression) using the same training and test sets in five 10-fold cross-validations after permuting the initial dataset. Supplementary Table S3 . Performance comparison in the prediction of drug response in cancer cell lines between the proposed approaches and other published methods. Vector Regression) using the same training and test sets in five 10-fold cross-validations after permuting the initial dataset. Supplementary Table S5 . Contribution of each gene in the DSG set for a specific drug measured as the loss in terms of Pearson correlation between predicted and observed IC50 values (R pred-obs ). Only genes (rows) selected at least once in a DSG set are shown; genes with a value of 0 are not part of the DSG set for that particular drug (columns). Supplementary Table S6 . A) Intersection between the DSG of each drug and the genes coding for protein in the pathways associated to the known targets of the drug (gene set F2 in Supplementary Table S1 ). B) Drug-unique genes selected for each drug in the dataset. Supplementary Table S7 . PubChem IDs and SMILE representation of the structure of the drugs analyzed in the paragraph " Variability of the response mechanisms among similar drugs".
Supplementary Table S4. A)

